JPS627324Y2 - - Google Patents
Info
- Publication number
- JPS627324Y2 JPS627324Y2 JP1982028329U JP2832982U JPS627324Y2 JP S627324 Y2 JPS627324 Y2 JP S627324Y2 JP 1982028329 U JP1982028329 U JP 1982028329U JP 2832982 U JP2832982 U JP 2832982U JP S627324 Y2 JPS627324 Y2 JP S627324Y2
- Authority
- JP
- Japan
- Prior art keywords
- analgesic
- diode
- adhesive
- conductive layer
- lead wires
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000000202 analgesic effect Effects 0.000 claims description 18
- 239000000853 adhesive Substances 0.000 claims description 15
- 230000001070 adhesive effect Effects 0.000 claims description 15
- 239000000730 antalgic agent Substances 0.000 claims description 11
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 11
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 10
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 5
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 claims description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 4
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 claims description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 2
- 229940116229 borneol Drugs 0.000 claims description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 2
- 229960001047 methyl salicylate Drugs 0.000 claims description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims 1
- 235000019477 peppermint oil Nutrition 0.000 claims 1
- 239000010410 layer Substances 0.000 description 12
- 239000012790 adhesive layer Substances 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 3
- 229910052732 germanium Inorganic materials 0.000 description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Landscapes
- Electrotherapy Devices (AREA)
- Medicinal Preparation (AREA)
Description
【考案の詳細な説明】
本考案はダイオード及び鎮痛消炎剤よりなる鎮
痛部材に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an analgesic member comprising a diode and an analgesic and anti-inflammatory agent.
近時ダイオードを皮膚に貼付してダイオードの
整流作用又は起電力を利用して不定愁訴等を治療
する療法が提案（たとえば、医道の日本発行「医
道の日本」、第421号、第422号、第426号、第428
号及び第432号など参照）されている。 Recently, a therapy has been proposed in which a diode is pasted on the skin and the rectifying action or electromotive force of the diode is used to treat indefinite complaints (for example, "Ido no Nihon" published by Ido Japan, No. 421, No. 422, No. 426, No. 428
No. 432).
ところで、本考案者らはこのダイオード療法に
ついて種々研究を重ねてきたところ、ダイオード
及び、鎮痛消炎剤を併用すると、鎮痛作用におい
て相乗効果を示すことを見出し、さらに研究を重
ねてダイオード及び鎮痛消炎剤よりなり、かつ取
扱いの簡便な鎮痛部材を完成した。 By the way, the inventors of the present invention have conducted various studies on this diode therapy, and found that when a diode and an analgesic and anti-inflammatory drug are used in combination, a synergistic effect is shown in the analgesic effect. We have completed an analgesic member that is both flexible and easy to handle.
本考案は、粘着シート上のほぼ中央部に、間〓
部分を残して導電層が設けられ、当該間〓部分に
両端リード線付きダイオードが設置され、しかも
両端リード線付きダイオードがそのリード線部分
において導電層にて固定され、かつ少なくとも導
電層および／または粘着シートの粘着剤中に鎮痛
消炎剤が配合されてなる鎮痛部材に関するもので
ある。 This invention has a space between approximately the center of the adhesive sheet.
A conductive layer is provided with a portion remaining, a diode with lead wires at both ends is installed in the intervening portion, and the diode with lead wires at both ends is fixed by the conductive layer at the lead wire portion, and at least the conductive layer and/or This invention relates to an analgesic member in which an analgesic and anti-inflammatory agent is blended into the adhesive of an adhesive sheet.
本考案にて使用されるダイオードとしては、従
来ダイオード療法用として用いられているものが
いずれも使用可能であり、たとえばシリコンPN
接合型；ゲルマニウム型；ゲルマニウム、ヒ素等
からなる発光ダイオードなどがあげられる。特に
経済性を考慮した場合には、シリコン整流ダイオ
ード、スイチングダイオード、ゲルマニウム検波
用ダイオード等が好ましい。 As the diode used in this invention, any diode conventionally used for diode therapy can be used, such as silicon PN.
Junction type; germanium type; light emitting diodes made of germanium, arsenic, etc., and the like. Particularly when considering economic efficiency, silicon rectifier diodes, switching diodes, germanium detection diodes, and the like are preferable.
また、本考案にて使用される鎮痛消炎剤として
は、たとえばサリチル酸メチル、サリチル酸モノ
グリコール、ｌ−メントール、dl−カンフル、ｄ
−カンフル、ハツカ油、ボルネオールなどがあげ
られる。 In addition, the analgesic and anti-inflammatory agents used in the present invention include, for example, methyl salicylate, monoglycol salicylate, l-menthol, dl-camphor, dl-camphor,
- Examples include camphor, pepper oil, and borneol.
以下、本考案の治療部材の具体例を図面を用い
て説明する。 Hereinafter, specific examples of the treatment member of the present invention will be explained using the drawings.
第１図Ａ及びＢにおいて、１は粘着シートであ
り、それはプラスチツクフイルム、布、不織布、
紙などからなる柔軟な支持体１１と鎮痛消炎剤が
配合されていてもよい粘着剤層１２にて構成され
ている。２はダイオード本体で、３，３′はリー
ド線である。４，４′は鎮痛消炎剤を含んでいて
もよい導電層で、当該層４，４′は一般にゴム及
び／又は合成樹脂類と導電性粉末（例えば、カー
ボン、金属粉など）、さらには必要に応じて鎮痛
消炎剤を配合してなる組成物より構成されるもの
である。当該層４，４′は粘着シート１面上のほ
ぼ中央部に間〓部分を残して（たとえば接着剤、
溶着などの接着手段にて）固着されている。そし
て前記ダイオード本体２は前記間〓部分に装設さ
れ、またリード線３，３′は、夫々当該４，４′中
に挿入されて固着され、リード線３，３′と皮膚
面とは導電層４，４′を介して通電されるよう構
成されている。 In FIGS. 1A and B, 1 is an adhesive sheet, which can be made of plastic film, cloth, nonwoven fabric,
It is composed of a flexible support 11 made of paper or the like and an adhesive layer 12 which may contain an analgesic and anti-inflammatory agent. 2 is the diode body, and 3 and 3' are lead wires. 4, 4' is a conductive layer which may contain an analgesic and anti-inflammatory agent, and the layer 4, 4' generally contains rubber and/or synthetic resins and conductive powder (e.g. carbon, metal powder, etc.), and further contains necessary materials. It is composed of a composition containing an analgesic and anti-inflammatory agent depending on the condition. The layers 4 and 4' are formed by leaving a gap approximately in the center on one surface of the adhesive sheet (for example, adhesive,
(by adhesive means such as welding). The diode main body 2 is installed in the space between the two, and the lead wires 3, 3' are inserted into and fixed in the 4, 4', respectively, and the lead wires 3, 3' and the skin surface are electrically conductive. It is configured to be electrically conductive through the layers 4, 4'.
第２図の実例は導電層４，４′と粘着シート１
との間に、支持体１１と同様の材料からなる柔軟
な担持体５が固着されたものである。 The example in Figure 2 shows conductive layers 4, 4' and adhesive sheet 1.
A flexible support 5 made of the same material as the support 11 is fixed between the support 11 and the support 11.
第３図の実例は、導電性接着層４ａ，４a′と粘
着シート１との間にゴム及び／又は合成樹脂から
なるスペーサ６，６′が固着され、このスペーサ
と導電性接着層４ａ，４a′との間に、リード線
３，３′がサンドイツチされている構成を有する
ものである。 In the example shown in FIG. 3, spacers 6, 6' made of rubber and/or synthetic resin are fixed between the conductive adhesive layers 4a, 4a' and the adhesive sheet 1. The lead wires 3, 3' are sandwiched between the lead wires 3 and 3'.
上記の導電性粘着層４ａ，４a′は、含水ゲル粘
着物質又は、ゴム及び／又は合成樹脂類を主体と
する粘着性物質と導電性粉末、さらに必要に応じ
て鎮痛消炎剤を配合してなる組成物よりなるもの
であり、このような感圧接着剤を用いると、確実
な接触状態が維持されるという利点がある。 The conductive adhesive layers 4a, 4a' are formed by blending a hydrogel adhesive substance or an adhesive substance mainly composed of rubber and/or synthetic resin with conductive powder and, if necessary, an analgesic and anti-inflammatory agent. The use of such a pressure-sensitive adhesive has the advantage that reliable contact is maintained.
第４図の実例は、第３図におけるスペーサ６，
６′の代りに予め、担持体５の表面に感圧接着剤
層７を全面又は、部分的に形成したものを用いた
ものであり、ダイオード本体２も当該接着剤層７
に貼着されているので、浮き上つたりすることの
ないものである。 The example in FIG. 4 is the spacer 6 in FIG.
In place of 6', a pressure-sensitive adhesive layer 7 is formed on the entire surface or a part of the surface of the carrier 5 in advance, and the diode main body 2 is also coated with the adhesive layer 7.
Since it is attached to the surface, it will not float up or fall off.
本考案の治療部材は従来のダイオード療法具と
同様に皮膚に適用することによつて使用される。 The therapeutic device of the present invention is used by applying it to the skin in the same way as conventional diode therapy devices.
本考案の治療部材は、以上のようにダイオード
及び鎮痛消炎剤よりなるものであるところから、
それらの相乗効果によつて顕著な鎮痛効果が得ら
れるうえ、ダイオードのリード線が導電性層にて
被覆されているので皮膚が傷つけられることなく
しかも、導電性粘着層を最外面に形成したものに
あつては皮膚に対して良好なる密着状態が提供さ
れるという特徴を有する。 The treatment device of the present invention is composed of a diode and an analgesic and anti-inflammatory agent as described above.
The synergistic effect of these components provides a remarkable analgesic effect, and since the diode lead wires are covered with a conductive layer, the skin is not damaged, and in the case of those having a conductive adhesive layer formed on the outermost surface, good adhesion to the skin is provided.
第１図Ａは本考案の実例を示す斜視図、第１図
Ｂは第１図Ａを−′線で切断した断面図、第
２〜４図は他の実例を示す断面図である。
１……粘着シート、２……ダイオード本体、
３，３′……リード線、４，４′，４ａ，４a′……
導電層、５……担持体、６，６′……スペーサ、
７……感圧接着剤層、１１……支持体、１２……
粘着剤層。
FIG. 1A is a perspective view showing an example of the present invention, FIG. 1B is a sectional view taken along the line -' of FIG. 1A, and FIGS. 2 to 4 are sectional views showing other examples. 1... Adhesive sheet, 2... Diode body,
3, 3'... Lead wire, 4, 4', 4a, 4a'...
conductive layer, 5... carrier, 6, 6'... spacer,
7...Pressure sensitive adhesive layer, 11...Support, 12...
Adhesive layer.
Claims (1)
して導電層が設けられ、当該間〓部分に両端リ
ード線付きダイオードが設置され、しかも両端
リード線付きダイオードがそのリード線部分に
おいて導電層にて固定され、かつ少なくとも導
電層及び／又は粘着シートの粘着剤中に、鎮痛
消炎剤が配合されてなる鎮痛部材。 (2) 鎮痛消炎剤がサリチル酸メチル、サリチル酸
モノグリコール、ｌ−メントール、dl−カンフ
ル、ｄ−カンフル、ハツカ油、ボルネオールか
ら選ばれる少くとも一種類である実用新案登録
請求の範囲第１項記載の鎮痛部材。[Claims for Utility Model Registration] (1) A conductive layer is provided approximately in the center of the adhesive sheet, leaving a gap, and a diode with lead wires at both ends is installed in the gap, and a diode with lead wires at both ends is installed in the gap. An analgesic member, wherein a diode is fixed at its lead wire portion with a conductive layer, and an analgesic and anti-inflammatory agent is blended in at least the conductive layer and/or the adhesive of the adhesive sheet. (2) Utility model registration claim 1, wherein the analgesic and anti-inflammatory agent is at least one selected from methyl salicylate, monoglycol salicylate, l-menthol, dl-camphor, d-camphor, peppermint oil, and borneol. Analgesic component.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2832982U JPS58131841U (en) | 1982-02-26 | 1982-02-26 | analgesic component |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2832982U JPS58131841U (en) | 1982-02-26 | 1982-02-26 | analgesic component |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58131841U JPS58131841U (en) | 1983-09-06 |
| JPS627324Y2 true JPS627324Y2 (en) | 1987-02-20 |
Family
ID=30040184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2832982U Granted JPS58131841U (en) | 1982-02-26 | 1982-02-26 | analgesic component |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58131841U (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2545223Y2 (en) * | 1989-08-09 | 1997-08-25 | ダイコク電機 株式会社 | Game machine signal processor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58131837U (en) * | 1982-02-25 | 1983-09-06 | 日東電工株式会社 | Indeterminate complaint treatment parts |
-
1982
- 1982-02-26 JP JP2832982U patent/JPS58131841U/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58131841U (en) | 1983-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3479294D1 (en) | Applicator for the non-invasive transcutaneous delivery of medicament | |
| JPS627324Y2 (en) | ||
| JPH0356429U (en) | ||
| JPS6136284Y2 (en) | ||
| JPS6136283Y2 (en) | ||
| JPS627323Y2 (en) | ||
| JPS6122604Y2 (en) | ||
| JPS6155394B2 (en) | ||
| JPS623158Y2 (en) | ||
| JPS6323087Y2 (en) | ||
| JPS62106995U (en) | ||
| JPS63178092U (en) | ||
| JPS6213056Y2 (en) | ||
| JPS58149768A (en) | Member for treating indifinite depressant | |
| JPS6438971U (en) | ||
| JPS6280515U (en) | ||
| JPH0364256U (en) | ||
| JPH0330242U (en) | ||
| JPS63137494U (en) | ||
| JPH0166211U (en) | ||
| JPS61127515U (en) | ||
| JPS61121480U (en) | ||
| JPS6382318U (en) | ||
| JPS63197539U (en) | ||
| JPS61145634U (en) |